New formulation containing polyethylene glycol (peg) conjugated interferon alpha-2beta characterised by less painful administration
RU2577228C2
Anti-il-17 antibodies, methods of their production and application
RU2576372C2
PEG-MODIFIED HUMAN INTERFERON β-1a MOLECULE WITH ANTIVIRAL, IMMUNOMODULATORY AND ANTIPROLIFERATIVE ACTIVITY, WITH IMPROVED STABILITY, REDUCED IMMUNOGENICITY, IMPROVED PHARMACOKINETIC AND PHARMACODYNAMIC PARAMETERS, SUITABLE FOR MEDICAL USE, AND IMMUNOBIOLOGICAL FORMULATION BASED THEREON
RU2447083C1
NOVEL FUNCTIONALLY ACTIVE, HIGHLY PURE, STABLE CONJUGATE OF INTERFERON α WITH POLYETHYLENE GLYCOL, REPRESENTED BY ONE PEG- NαH-IFN POSITIONAL ISOMER, WITH IMPROVED IMMUNOGENICITY, WITH PROLONGED BIOLOGICAL ACTION, SUITABLE FOR MEDICAL APPLICATION, AND IMMUNOLOGICAL AGENT BASED THEREON
RU2414915C2
Method for producing activated leukocytes for adjuvant adoptive immunotherapy of malignant growths
RU2428175C2
Method of obtaining parenteral pharmaceutical solution
RU2408378C2
Method of treating chronic prostatitis
RU2370258C2
Pharmaceutical composition for parenteral delivery in form of lyophilizate and method of its obtaining
RU2370261C2
Stable emulsion for parenteral introduction of badly soluble in water compounds, which have anti-tumor activity, and method of its obtaining
RU2356535C2
Synergistic suppositories for infectious gynecopathies treatment (versions)
RU2355400C2
Method of obtaining and purification of gemcitabine hydrochloride
RU2326168C1
RECOMBINANT PLASMID DNA pIF TREN CODING HUMAN POLYPEPTIDE OF ALFA-2b INTERFERON AND POLYPEPTIDE OF Escherichia BACTERIA RACE coli-PRODUCER OF HUMAN ALFA-2b INTERFERON
RU2326169C1
RECOMBINANT PLASMID DNA pA3GF CODING POLYPEPTIDE OF HUMAN GRANULOCYTE COLONY-STIMULATING FACTOR, AND Escherichia BACTERIA RACE coli-PRODUCER OF HUMAN GRANULOCYTE COLONY-STIMULATING FACTOR POLYPEPTIDE
